November 2, 2026 · Annals of internal medicine · DOI: 10.7326/ANNALS-26-03882-JC

Use of GLP-1 RAs before or during pregnancy was not linked to maternal pregnancy complications.

Listen to this summary

This commentary-style item, published in *Annals of Internal Medicine*, appears to ask whether using GLP-1 receptor agonists (a class of diabetes and weight-loss drugs) before or during pregnancy is associated with maternal pregnancy complications. Its title suggests the answer was no, that such use was not linked to these complications. The abstract provided is only a placeholder, so the study design, sample, and specific outcomes could not be verified.

Meera Jain, Liz Stephens

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play